Observational studyInternational journal of urology : official journal of the Japanese Urological Association2026
Post-Marketing Surveillance of the Safety and Effectiveness of Cabozantinib in Japanese Patients With Advanced Renal Cell Carcinoma.
Hiro-Omi Kanayama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.